Back to mobile site

Benchmark Reiterates Buy Rating on agilon health Inc (AGL)

September 29, 2025 7:34 AM EDT Send to a Friend
Benchmark analyst Bill Sutherland reiterated a Buy rating and $1.50 price target on agilon health Inc (NYSE: AGL).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login